EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Herpes simplex virus 1 inhibits phosphorylation of RNA polymerase II CTD serine-7

Adam W Whisnant iD, Oliver Dyck Dionisi iD, Valeria Salazar Sanchez, Julia M Rappold, Lara Djakovic, Arnhild Grothey, Ana Luiza Marante, Patrick Fischer, Shitao Peng, Katharina Wolf, Thomas Hennig iD, Lars Dölken iD

Journal of Virology · 2024

DOI: 10.1128/jvi.01178-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Adam W Whisnant und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: RNA Polymerase II, Herpesvirus 1, Human, Serine, Immediate-Early Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), EC | European Research Council (ERC), Alexander von Humboldt-Stiftung (AvH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcriptional activity of RNA polymerase II (Pol II) is influenced by post-translational modifications of the C-terminal domain (CTD) of the largest Pol II subunit, RPB1. Herpes simplex virus type 1 (HSV-1) usurps the cellular transcriptional machinery during lytic infection to efficiently express viral mRNA and shut down host gene expression. The viral immediate-early protein ICP22 interferes with serine 2 phosphorylation (pS2) by targeting CDK9 and other CDKs, but the full functional implications of this are not well understood. Using Western blotting, we report that HSV-1 also induces a loss of serine 7 phosphorylation (pS7) of the CTD during lytic infection, requiring expression of the two immediate-early proteins ICP22 and ICP27. ICP27 has also been proposed to target RPB1 for degradation, but we show that pS2/S7 loss precedes the drop in total protein levels. Cells with the RPB1 polyubiquitination site mutation K1268R, preventing proteasomal degradation during transcription-coupled DNA repair, displayed loss of pS2/S7 but retained higher overall RPB1 protein levels later in infection, indicating this pathway is not involved in early CTD dysregulation but may mediate bulk protein loss later. Using α-amanitin-resistant CTD mutants, we observed differential requirements for Ser2 and Ser7 for the production of viral proteins, with Ser2 facilitating viral immediate-early genes and Ser7 appearing dispensable. Despite dysregulation of CTD phosphorylation and different requirements for Ser2/7, all CTD modifications tested could be visualized in viral replication compartments with immunofluorescence. These data expand the known means that HSV employs to create pro-viral transcriptional environments at the expense of host responses. IMPORTANCE Cells rapidly induce changes in the transcription of RNA in response to stress and pathogens. Herpes simplex virus (HSV) disrupts many processes of host mRNA transcription, and it is necessary to separate the actions of viral proteins from cellular responses. Here, we demonstrate that viral proteins inhibit two key phosphorylation patterns on the C-terminal domain (CTD) of cellular RNA polymerase II and that this is separate from the degradation of polymerases later in infection. Furthermore, we show that viral genes do not require the full “CTD code.” Together, these data distinguish multiple steps in the remodeling of RNA polymerase during infection and suggest that shared transcriptional phenotypes during stress responses do not revolve around a core disruption of CTD modifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Polymerase IIHerpesvirus 1, HumanSerineImmediate-Early ProteinsPhosphorylationHumansVirus ReplicationProtein Processing, Post-TranslationalAnimalsChlorocebus aethiopsCyclin-Dependent Kinase 9Vero CellsTranscription, GeneticViral ProteinsHerpes Simplex

Stichwörter der Autor:innen

RNA polymerasesherpes simplex virustranscription

Substanzen

RNA Polymerase IISerineImmediate-Early ProteinsICP22 protein, human herpesvirus 1ICP27 protein, human herpesvirus 1Cyclin-Dependent Kinase 9Viral Proteins

Autor:innen und Institutionen

  • Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
  • Hannover Medical School, Institute of Virology, Hannover, Germany.

ORCID-Profile: Adam W Whisnant, Oliver Dyck Dionisi, Thomas Hennig, Lars Dölken

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)
  • EC | European Research Council (ERC)
  • Alexander von Humboldt-Stiftung (AvH)

Zitieren

APA

Whisnant, A. W., Dyck Dionisi, O., Salazar Sanchez, V., Rappold, J. M., Djakovic, L., Grothey, A., Marante, A. L., Fischer, P., Peng, S., Wolf, K., Hennig, T., & Dölken, L. (2024). Herpes simplex virus 1 inhibits phosphorylation of RNA polymerase II CTD serine-7. Journal of Virology. https://doi.org/10.1128/jvi.01178-24

Vancouver

Whisnant AW, Dyck Dionisi O, Salazar Sanchez V, Rappold JM, Djakovic L, Grothey A, et al. Herpes simplex virus 1 inhibits phosphorylation of RNA polymerase II CTD serine-7. Journal of Virology. 2024. doi:10.1128/jvi.01178-24

BibTeX
@article{Whisnant2024,
  author = {Whisnant, Adam W and Dyck Dionisi, Oliver and Salazar Sanchez, Valeria and Rappold, Julia M and Djakovic, Lara and Grothey, Arnhild and Marante, Ana Luiza and Fischer, Patrick and Peng, Shitao and Wolf, Katharina and Hennig, Thomas and Dölken, Lars},
  title = {Herpes simplex virus 1 inhibits phosphorylation of RNA polymerase II CTD serine-7},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01178-24}
}
Kostenlos starten →